| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06660810 | Neoadjuvant Intralesional Injection of Talimogene Laherparepvec | Soft Tissue Sarcoma | Active, Not Recruiting |
| NCT02923778 | Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed… | Leiomyosarcoma | Active, Not Recruiting |
| NCT02978625 | Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or… | Anaplastic Large Cell Lymphoma, ALK-Negative | Active, Not Recruiting |
| NCT02965716 | Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma | Advanced Melanoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04599062 | TVEC and Preop Radiation for Sarcoma (8 ml Dose) | Soft Tissue Sarcoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT07102394 | Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in… | NF1 | Recruiting |